Many roads lead to oncogene-induced senescence
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Oncogene-induced senescence is a mechanism of tumor suppression that restricts the progression of benign tumors. Important advances have been made toward elucidating the mechanisms that regulate this response; however, there is presently no unified model that integrates all current findings. DNA damage, replicative stress, reactive oxygen species, heterochromatin formation and negative feedback signaling networks have all been proposed to play an integral role in promoting senescence in response to various oncogenic insults. In all cases, these signals have been shown to function through Rb and p53, but utilize different intermediaries. Thus, it appears that senescence is not triggered by a single, linear series of events, but instead is regulated by a complex signaling network. Accordingly, multiple proteins may cooperate to establish a senescence response, but the limiting signal(s) may be dictated by the initiating genetic alteration and/or tissue type. This review will focus on integrating current models and will highlight data that provide new insight into the signals that function to suppress human tumor development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oncogene-induced senescence (OIS), characterized by aberrant DNA replication and the associated DNA damage response, is affected by activated oncogenes or the loss of tumor-suppressor genes in healthy cells”
From Redox control of senescence and age-related disease. (2017) · cites this paper as [61]
In the citing paper
“The activation of only one or both pathways for the execution and maintenance of the senescence program is dictated by the type of stress signal, the tissue, and the species of origin [67], or by a compensatory response to signaling imbalances.”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [67]
In the citing paper
“A hallmark of senescence is its stable cell cycle arrest coordinated by interplay between the RB and p53 tumor suppressor networks (Courtois-Cox et al., 2008).”
From Dissecting the Unique Role of the Retinoblastoma Tumor Suppressor during Cellular Senescence (2010) · cites this paper as Courtois-Cox et al., 2008
In the citing paper
“In addition to the RB pathway, the p53 tumor suppressor also contributes to senescence (Courtois-Cox et al., 2008).”
From Dissecting the Unique Role of the Retinoblastoma Tumor Suppressor during Cellular Senescence (2010) · cites this paper as Courtois-Cox et al., 2008
In the citing paper
“strong evidence places RB–E2F activity and associated chromatin-regulating complexes, such as SUV39H1, as a key regulators of senescence in cells in culture121–124.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [123]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 3×
“The earliest in vitro studies demonstrated that oncogeneinduced senescence could be bypassed by inactivating Rb and p53 (Serrano et al., 1997).”
BackgroundResultInfluentialTumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804 · cited 1×
“However, even at this time, additional cooperating genetic alterations were known to be required for Ras to transform primary cells (Land et al., 1983).”
BackgroundHingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473 · cited 2×
“However, several studies have now established a more causal role for senescence in this process (Sarkisian et al., 2007; Ventura et al., 2007; Xue et al., 2007).”
BackgroundResultRb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 2×
“SAHFs accumulate during oncogene-induced senescence through a multi-step process and are thought to suppress stably the expression of E2F target genes via the recruitment of Rb and heterochromatin proteins (Narita et al., 2003; Adams et al., 2007).”
BackgroundBRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160 · cited 2×
“However, several reports have now demonstrated that oncogene-induced senescence does indeed occur in vivo in human tumors and in mouse tumor models (Braig et al., 2005; Chen et al., 2005; Collado et al., 2005; Michaloglou et al., 2005; Courtois-Cox et al., 2006; Dankort et al., 2007; Sarkisian et al., 2007).”
BackgroundCrucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993 · cited 5×
“…reports have now demonstrated that oncogene-induced senescence does indeed occur in vivo in human tumors and in mouse tumor models (Braig et al., 2005; Chen et al., 2005; Collado et al., 2005; Michaloglou et al., 2005; Courtois-Cox et al., 2006; Dankort et al., 2007; Sarkisian et al., 2007).”
BackgroundResultInfluentialOncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986 · cited 2×
“Moreover, it appears that at least a subset of oncogenes can only trigger senescence if cells are allowed to enter S phase (Bartkova et al., 2006; Di Micco et al., 2006).”
BackgroundOncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821 · cited 3×
“Consistent with this model, Di Micco et al. (2006) have shown that senescent cells stall in S phase, have an augmented number of active replicons and exhibit defects in DNA replication fork progression, resulting in an activation of ATR and ultimately ATM.”
BackgroundRestoration of p53 function leads to tumour regression in vivo
Ventura, A., Kirsch, D. G., McLaughlin, M. E., Tuveson, D. A., Grimm, J., Lintault, L., Newman, J., Reczek, E. E., Weissleder, R., & Jacks, T. (2007) · Nature · doi:10.1038/nature05541 · Cited by 1,820 · cited 2×
“However, several studies have now established a more causal role for senescence in this process (Sarkisian et al., 2007; Ventura et al., 2007; Xue et al., 2007).”
BackgroundResultSenescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482 · cited 5×
“, 2007), and would be presumed to be senescent, on the basis of other published studies (Collado et al., 2005).”
BackgroundResultInfluentialOncogene-induced senescence as an initial barrier in lymphoma development
Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A. H. F. M., Schlegelberger, B., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A. (2005) · Nature · doi:10.1038/nature03841 · Cited by 1,220 · cited 2×
“However, several reports have now demonstrated that oncogene-induced senescence does indeed occur in vivo in human tumors and in mouse tumor models (Braig et al., 2005; Chen et al., 2005; Collado et al., 2005; Michaloglou et al., 2005; Courtois-Cox et al., 2006; Dankort et al., 2007; Sarkisian et al., 2007).”
BackgroundOxygen sensitivity severely limits the replicative lifespan of murine fibroblasts
Parrinello, S., Samper, E., Krtolica, A., Goldstein, J., Melov, S., & Campisi, J. (2003) · Nature Cell Biology · doi:10.1038/ncb1024 · Cited by 1,116 · cited 1×
“Consistent with this hypothesis, oncogeneinduced senescence can be bypassed in murine cells by growing cells in low oxygen (Lee et al., 1999; Parrinello et al., 2003; MacLaren et al., 2004).”
BackgroundFoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis
Paik, J.-H., Kollipara, R., Chu, G., Ji, H., Xiao, Y., Ding, Z., Miao, L., Tothova, Z., Horner, J. W., Carrasco, D. R., et al. (2007) · Cell · doi:10.1016/j.cell.2006.12.029 · Cited by 1,032 · cited 1×
“In a surprising twist, Paik et al. (2007) have also found that Sprouty 2 is a direct target of FOXO , raising the possibility that a positive feedback loop may function within this negative feedback pathway.”
BackgroundThe role of apoptosis in cancer development and treatment response
Brown, J. M., & Attardi, L. D. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1560 · Cited by 944
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene
Parada, L. F., Tabin, C. J., Shih, C., & Weinberg, R. A. (1982) · Nature · doi:10.1038/297474a0 · Cited by 944 · cited 1×
“In 1982, ras was identified as a human oncogene and activated Ras proteins were shown to be capable of transforming immortalized rodent cells (Der et al., 1982; Parada et al., 1982).”
BackgroundDer, C. J., Krontiris, T. G., & Cooper, G. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.11.3637 · Cited by 800 · cited 1×
“In 1982, ras was identified as a human oncogene and activated Ras proteins were shown to be capable of transforming immortalized rodent cells (Der et al., 1982; Parada et al., 1982).”
BackgroundTuveson, D. A., Shaw, A. T., Willis, N. A., Silver, D. P., Jackson, E. L., Chang, S., Mercer, K. L., Grochow, R., Hock, H., Crowley, D., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00085-6 · Cited by 798 · cited 3×
“Moreover, this allele did not induce the cellular senescence of mouse embryonic fibroblasts (MEFs), but rather resulted in their immortalization, supporting the possibility that at least in this cell type, senescence might be an artifact of Ras overexpression (Tuveson et al., 2004).”
BackgroundMethodRas Proteins Induce Senescence by Altering the Intracellular Levels of Reactive Oxygen Species
Lee, A. C., Fenster, B. E., Ito, H., Takeda, K., Bae, N. S., Hirai, T., Yu, Z.-X., Ferrans, V. J., Howard, B. H., & Finkel, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7936 · Cited by 691 · cited 3×
“One model suggests that DNA damage is caused by an oncogene-driven accumulation of reactive oxygen species (ROS) (Lee et al., 1999).”
BackgroundPten Dose Dictates Cancer Progression in the Prostate
Trotman, L. C., Niki, M., Dotan, Z. A., Koutcher, J. A., Di Cristofano, A., Xiao, A., Khoo, A. S., Roy-Burman, P., Greenberg, N. M., Dyke, T. V., et al. (2003) · PLoS Biology · doi:10.1371/journal.pbio.0000059 · Cited by 676 · cited 1×
“However, while AKT is phosphorylated in these lesions, it is exclusively cytoplasmic (Trotman et al., 2003).”
BackgroundAberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients
Basu, T. N., Gutmann, D. H., Fletcher, J. A., Glover, T. W., Collins, F. S., & Downward, J. (1992) · Nature · doi:10.1038/356713a0 · Cited by 668 · cited 1×
“NF1 encodes a RasGAP protein, and its inactivation has been shown to cause an acute activation of (endogenous) Ras and Ras effector pathways (Basu et al., 1992; DeClue et al., 1992).”
BackgroundA novel role for high-mobility group A proteins in cellular senescence and heterochromatin formation
Narita, M., Narita, M., Krizhanovsky, V., Nuñez, S., Chicas, A., Hearn, S. A., Myers, M. P., & Lowe, S. W. (2006) · Cell · doi:10.1016/j.cell.2006.05.052 · Cited by 629
Dinulescu, D. M., Ince, T. A., Quade, B. J., Shafer, S. A., Crowley, D., & Jacks, T. (2005) · Nature Medicine · doi:10.1038/nm1173 · Cited by 604 · cited 2×
“…crossed to other tumor-prone strains to generate animals with compound mutations, the resulting tumors do exhibit activation of Ras effectors, implying that this suppression is somehow alleviated in the course of tumor development and/or progression (Dinulescu et al., 2005; Hingorani et al., 2005).”
BackgroundDeClue, J. E., Papageorge, A. G., Fletcher, J. A., Diehl, S. R., Ratner, N., Vass, W. C., & Lowy, D. R. (1992) · Cell · doi:10.1016/0092-8674(92)90407-4 · Cited by 580 · cited 1×
“NF1 encodes a RasGAP protein, and its inactivation has been shown to cause an acute activation of (endogenous) Ras and Ras effector pathways (Basu et al., 1992; DeClue et al., 1992).”
BackgroundTumor induction by an endogenous K-ras oncogene is highly dependent on cellular context
Guerra, C., Mijimolle, N., Dhawahir, A., Dubus, P., Barradas, M., Serrano, M., Campuzano, V., & Barbacid, M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00191-0 · Cited by 571 · cited 1×
“This hypothesis was fueled by the development and characterization of mouse models that were designed to express a single activated K-ras allele driven by its endogenous promoter (Guerra et al., 2003; Tuveson et al., 2004).”
MethodA negative feedback signaling network underlies oncogene-induced senescence
Courtois-Cox, S., Genther Williams, S. M., Reczek, E. E., Johnson, B. W., McGillicuddy, L. T., Johannessen, C. M., Hollstein, P. E., MacCollin, M., & Cichowski, K. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.003 · Cited by 501 · cited 12×
“This hypothesis has been formally proven by analysing the consequences of inactivating the NF1 tumor suppressor, the gene responsible for the familial cancer syndrome neurofibromatosis type I (NF1) (Courtois-Cox et al., 2006).”
BackgroundInfluentialSelf-citationDose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis
Sarkisian, C. J., Keister, B. A., Stairs, D. B., Boxer, R. B., Moody, S. E., & Chodosh, L. A. (2007) · Nature Cell Biology · doi:10.1038/ncb1567 · Cited by 490 · cited 5×
“However, several studies have now established a more causal role for senescence in this process (Sarkisian et al., 2007; Ventura et al., 2007; Xue et al., 2007).”
BackgroundInfluentialRepression of c- fos Transcription and an Altered Genetic Program in Senescent Human Fibroblasts
Seshadri, T., & Campisi, J. (1990) · Science · doi:10.1126/science.2104680 · Cited by 481 · cited 2×
“In light of this finding, it should be noted that one of the classical definitions of senescence is that senescent cells are incapable of triggering the expression of genes required for proliferation in response to growth factors (Seshadri and Campisi, 1990).”
BackgroundDankort, D., Filenova, E., Collado, M., Serrano, M., Jones, K., & McMahon, M. (2007) · Genes & Development · doi:10.1101/gad.1516407 · Cited by 481 · cited 2×
“However, several reports have now demonstrated that oncogene-induced senescence does indeed occur in vivo in human tumors and in mouse tumor models (Braig et al., 2005; Chen et al., 2005; Collado et al., 2005; Michaloglou et al., 2005; Courtois-Cox et al., 2006; Dankort et al., 2007; Sarkisian et al., 2007).”
BackgroundGermline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1–like phenotype
Brems, H., Chmara, M., Sahbatou, M., Denayer, E., Taniguchi, K., Kato, R., Somers, R., Messiaen, L., De Schepper, S., Fryns, J.-P., et al. (2007) · Nature Genetics · doi:10.1038/ng2113 · Cited by 472 · cited 1×
“Moreover, the Sprouty-related gene SPRED 1 has recently been reported to be genetically inactivated in a syndrome with features similar to NF1 (Brems et al., 2007).”
BackgroundCHEN, Q. M., BARTHOLOMEW, J. C., CAMPISI, J., ACOSTA, M., REAGAN, J. D., & AMES, B. N. (1998) · Biochemical Journal · doi:10.1042/bj3320043 · Cited by 445 · cited 2×
“Certainly, ROS have well-known DNA-damaging effects, and agents that cause accumulation of ROS can trigger cellular senescence, which will be discussed below (Chen et al., 1998; Frippiat et al., 2000).”
BackgroundThe DNA damage signaling pathway is a critical mediator of oncogene-induced senescence
Mallette, F. A., Gaumont-Leclerc, M.-F., & Ferbeyre, G. (2007) · Genes & Development · doi:10.1101/gad.1487307 · Cited by 406 · cited 1×
“Moreover, while inactivation of ATM is sufficient to bypass senescence triggered by some oncogenes in some cell types, other studies demonstrate that additional senescence regulators must also be inactivated, indicating that multiple pathways can be simultaneously engaged (Mallette et al., 2007).”
Backgroundp38α MAP Kinase as a Sensor of Reactive Oxygen Species in Tumorigenesis
Dolado, I., Swat, A., Ajenjo, N., De Vita, G., Cuadrado, A., & Nebreda, A. R. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.013 · Cited by 404 · cited 1×
“Despite these findings, not all oncogenes increase ROS (for example, Raf, myc; Ray et al., 2006; Dolado et al., 2007), and it is still unknown whether a single activated Ras allele is capable of inducing sufficiently high levels of ROS.”
BackgroundDimri, G. P., Itahana, K., Acosta, M., & Campisi, J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.1.273-285.2000 · Cited by 395
Identification of a tumour suppressor network opposing nuclear Akt function
Trotman, L. C., Alimonti, A., Scaglioni, P. P., Koutcher, J. A., Cordon-Cardo, C., & Pandolfi, P. P. (2006) · Nature · doi:10.1038/nature04809 · Cited by 394 · cited 3×
“Accordingly, along with promoting the development of more advanced tumors in the PTEN model, loss of PML results in the nuclear accumulation of activated AKT and inactivation of FOXO-3a, a nuclear target of AKT (Trotman et al., 2006).”
BackgroundInfluentialModulation of signalling by Sprouty: a developing story
Kim, H. J., & Bar-Sagi, D. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1400 · Cited by 372 · cited 2×
“Specifically, Shaw et al. (Shaw et al., 2007) showed that activation of a single mutant K-ras allele in the lung resulted in a dramatic upregulation of Sprouty 2, an established negative regulator of Ras signaling (Kim and Bar-Sagi, 2004; Shaw et al., 2007).”
BackgroundMiyauchi, H., Minamino, T., Tateno, K., Kunieda, T., Toko, H., & Komuro, I. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600045 · Cited by 336
PRAK Is Essential for ras-Induced Senescence and Tumor Suppression
Sun, P., Yoshizuka, N., New, L., Moser, B. A., Li, Y., Liao, R., Xie, C., Chen, J., Deng, Q., Yamout, M., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.050 · Cited by 321 · cited 1×
“While ROS can induce DNA damage, Sun et al. (2007) have also shown that ROS may trigger senescence via a kinase cascade involving p38 and one of its effector kinases known as PRAK, which can phosphorylate and activate p53.”
BackgroundMeier, F. (2005) · Frontiers in Bioscience · doi:10.2741/1755 · Cited by 267 · cited 1×
“In addition, mutant Raf alleles were found to be extremely potent inhibitors of PI3K signaling, providing an attractive explanation for why mutations in the Raf and PI3K pathway commonly cooperate in tumorigenesis (Meier et al., 2005; Ogawa et al., 2005).”
BackgroundYe, X., Zerlanko, B., Kennedy, A., Banumathy, G., Zhang, R., & Adams, P. D. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.034 · Cited by 228 · cited 1×
“Finally, another intriguing observation consistent with a role for negative feedback signaling in tumor suppression is the observation that suppression of WNT signaling may also participate in the senescence response (Ye et al., 2007).”
BackgroundRas Induces Vascular Smooth Muscle Cell Senescence and Inflammation in Human Atherosclerosis
Minamino, T., Yoshida, T., Tateno, K., Miyauchi, H., Zou, Y., Toko, H., & Komuro, I. (2003) · Circulation · doi:10.1161/01.cir.0000093274.82929.22 · Cited by 208
Denchi, E. L., Attwooll, C., Pasini, D., & Helin, K. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.7.2660-2672.2005 · Cited by 195
Regulation of cellular response to oncogenic and oxidative stress by Seladin-1
Wu, C., Miloslavskaya, I., Demontis, S., Maestro, R., & Galaktionov, K. (2004) · Nature · doi:10.1038/nature03173 · Cited by 192 · cited 1×
“Notably, ROS scavengers can suppress senescence in some systems, and inactivation of the seladin-1 gene, which has been proposed to be a sensor of ROS, is also sufficient to bypass Ras-induced senescence in BJ fibroblasts (Lee et al., 1999; Wu et al., 2004).”
BackgroundSansom, O. J., Meniel, V., Wilkins, J. A., Cole, A. M., Oien, K. A., Marsh, V., Jamieson, T. J., Guerra, C., Ashton, G. H., Barbacid, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604130103 · Cited by 187 · cited 3×
“For example, in the process of generating a mouse model of intestinal tumors, Sansom et al. (2006) showed that the expression of a single, activated K-ras allele was insufficient to trigger AKT or ERK activation in the intestine and reported that negative feedback pathways were responsible for…”
BackgroundInfluentialAdams, P. D. (2007) · Gene · doi:10.1016/j.gene.2007.04.020 · Cited by 176
Sprouty-2 regulates oncogenic K-ras in lung development and tumorigenesis
Shaw, A. T., Meissner, A., Dowdle, J. A., Crowley, D., Magendantz, M., Ouyang, C., Parisi, T., Rajagopal, J., Blank, L. J., Bronson, R. T., et al. (2007) · Genes & Development · doi:10.1101/gad.1526207 · Cited by 131 · cited 7×
“(Shaw et al., 2007) showed that activation of a single mutant K-ras allele in the lung resulted in a dramatic upregulation of Sprouty 2, an established negative regulator of Ras signaling (Kim and Bar-Sagi, 2004; Shaw et al.”
BackgroundResultInfluentialThe DNA Damage Signaling Pathway Connects Oncogenic Stress to Cellular Senescence
Mallette, F. A., & Ferbeyre, G. (2007) · Cell Cycle · doi:10.4161/cc.6.15.4516 · Cited by 125 · cited 5×
“2007), and some cell types appear to be incapable of forming SAHFs (Mallette and Ferbeyre, 2007).”
BackgroundInfluentialRole of Phosphoinositide 3-Kinase Regulatory Isoforms in Development and Actin Rearrangement
Brachmann, S. M., Yballe, C. M., Innocenti, M., Deane, J. A., Fruman, D. A., Thomas, S. M., & Cantley, L. C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.7.2593-2606.2005 · Cited by 123 · cited 1×
“This finding is consistent with the long-standing observation that PI3K-deficient MEFs cannot be established, as they rapidly become senescent in culture (Brachmann et al., 2005).”
ResultMYC Can Induce DNA Breaks In vivo and In vitro Independent of Reactive Oxygen Species
Ray, S., Atkuri, K. R., Deb-Basu, D., Adler, A. S., Chang, H. Y., Herzenberg, L. A., & Felsher, D. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3115 · Cited by 98 · cited 8×
“While ROS can induce DNA damage, Sun et al. (2007) have also shown that ROS may trigger senescence via a kinase cascade involving p38 and one of its effector kinases known as PRAK, which can phosphorylate and activate p53.”
BackgroundInfluentialSprouty and cancer: The first terms report
Lo, T. L., Fong, C. W., Yusoff, P., McKie, A. B., Chua, M., Leung, H. Y., & Guy, G. R. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.12.032 · Cited by 89 · cited 1×
“Sprouty genes have also been shown to be suppressed in breast, prostate and lung cancer (reviewed in Lo et al., 2006), providing circumstantial evidence that Sprouty proteins could play a broader role in tumor suppression.”
BackgroundThe role of apoptosis in cancer cell survival and therapeutic outcome
Kim, R., Emi, M., & Tanabe, K. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.11.3456 · Cited by 64 · cited 1×
“E-mail: kcichowski@rics.bwh.harvard.edu Oncogene (2008) 27, 2801–2809 & 2008 Nature Publishing Group All rights reserved 0950-9232/08 $30.00 www.nature.com/onc Attardi, 2005; Kim et al., 2006).”
BackgroundInfluentialMacLaren, A., Black, E. J., Clark, W., & Gillespie, D. A. F. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.20.9006-9018.2004 · Cited by 64 · cited 1×
“Consistent with this hypothesis, oncogeneinduced senescence can be bypassed in murine cells by growing cells in low oxygen (Lee et al., 1999; Parrinello et al., 2003; MacLaren et al., 2004).”
BackgroundOncogenes and senescence: breaking down in the fast lane
Hemann, M. T., & Narita, M. (2007) · Genes & Development · doi:10.1101/gad.1514207 · Cited by 63 · cited 2×
“However, while DNA damage appears to be one signal that can cause senescence (potentially via both mechanisms), not all oncogenes induce DNA damage (Hemann and Narita, 2007).”
BackgroundMouse Models of Human Non-Small-Cell Lung Cancer: Raising the Bar
KIM, C. F. B., JACKSON, E. L., KIRSCH, D. G., GRIMM, J., SHAW, A. T., LANE, K., KISSIL, J., OLIVE, K. P., SWEET-CORDERO, A., WEISSLEDER, R., et al. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.037 · Cited by 58 · cited 1×
“It is now becoming more generally apparent that many mouse tissues designed to express this single K-ras allele do not exhibit much if any ERK and AKT activation (Kim et al., 2005).”
BackgroundFrippiat, C., Chen, Q. M., Remacle, J., & Toussaint, O. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00167-4 · Cited by 52 · cited 2×
“Certainly, ROS have well-known DNA-damaging effects, and agents that cause accumulation of ROS can trigger cellular senescence, which will be discussed below (Chen et al., 1998; Frippiat et al., 2000).”
BackgroundHoltkamp, N., Mautner, V., Friedrich, R. E., Harder, A., Hartmann, C. J., Théallier-Jankó, Á., Hoffmann, K., & von Deimling, A. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0797-8 · Cited by 49 · cited 1×
“Consistent with the hypothesis that Sprouty may also function to attenuate the effects of NF1 mutations, Sprouty has been shown to be downregulated in human malignancies associated with NF1 as compared to cognate premalignant lesions (neurofibromas) (Holtkamp et al., 2004).”
BackgroundOgawa, K., Sun, C., & Horii, A. (2005) · Oncology Reports · doi:10.3892/or.14.6.1481 · Cited by 21 · cited 1×
“In addition, mutant Raf alleles were found to be extremely potent inhibitors of PI3K signaling, providing an attractive explanation for why mutations in the Raf and PI3K pathway commonly cooperate in tumorigenesis (Meier et al., 2005; Ogawa et al., 2005).”
Background
Cited by
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926
Zhan, T., Rindtorff, N., & Boutros, M. (2017) · Oncogene · doi:10.1038/onc.2016.304 · Cited by 2,626
Cellular senescence and the senescent secretory phenotype: therapeutic opportunities
Tchkonia, T., Zhu, Y., van Deursen, J., Campisi, J., & Kirkland, J. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64098 · Cited by 1,774
Cellular Senescence: Aging, Cancer, and Injury
Calcinotto, A., Kohli, J., Zagato, E., Pellegrini, L., Demaria, M., & Alimonti, A. (2019) · Physiological Reviews · doi:10.1152/physrev.00020.2018 · Cited by 1,270
“This biological clock, known as the “Hayflick limit,” is caused by a progressive shortening of telomeres upon each cell division and represents a physiological response to prevent genomic instability and therefore accumulation of DNA damage (79, 150).”
BackgroundInfluentialFreund, A., Patil, C. K., & Campisi, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.69 · Cited by 1,039
“Likewise, p53 is required for the growth arrest (Campisi and d’Adda di Fagagna, 2007; Courtois-Cox et al, 2008), but not the SASP; in fact, cells lacking functional p53 secrete markedly higher levels of most SASP factors.”
Background
Metadata
- Authors
- Courtois-Cox, S., Jones, S. L., & Cichowski, K.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Cichowski, K
- ORCID
- Cichowski, K
- Venue
- Oncogene
- Published
- 2008-01-14
- Volume
- 27
- Issue
- 20
- Pages
- 2801-2809
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2001353514
- Cited by
- 397
- References
- 57
- Citations by year
- 2026: 8 · 2025: 28 · 2024: 17 · 2023: 23 · 2022: 24 · 2021: 21 · 2020: 22 · 2019: 26 · 2018: 22 · 2017: 23 · 2016: 34 · 2015: 17 · 2014: 19 · 2013: 21 · 2012: 18
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- oncogene-induced senescence, tumor suppression, DNA damage, replicative stress, reactive oxygen species, heterochromatin formation, Rb, p53
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Humans, Oncogenes, Cellular Senescence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.